The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Human Vascular Permeability Factor
Open accessAbstract
Human vascular permeability factor (hVPF) is a glycoprotein that promotes fluid and protein leakage from blood vessels.The function of hVPF is at present unknown, but the potent bioactivities of this protein suggest that it could act during inflammation, wound healing, and tumor angiogenesis.hVPF was purified from serum-free conditioned medium of the human histiocytic lymphoma cell line U937 as a disulfide-linked dimeric 40-kDa protein that promoted dermal blood vessel leakage in guinea pigs at a dose of 20 ng (3 x lo-' M) and promoted in vitro endothelial cell growth at concentrations as low as 50 pM.Multiple forms of hVPF with apparent PI values > 7.5 were resolved using pH gradient electrophoresis.Antibodies against guinea pig vascular permeability factor were found to cross-react with hVPF.The N-terminal amino acid sequence of hVPF was similar to, but not identical with, the N-terminal sequence of guinea pig vascular permeability factor.A protein known as vascular permeability factor (VPF)' was first identified as a secreted product of guinea pig line 10 tumor cells in vitro (Senger et al., 1983) and has since been found to be synthesized by numerous human and rodent tumor cell lines (Senger et al., 1986).VPF is an extremely potent agent in promoting fluid and protein extravasation.It has been hypothesized (Dvorak et al., 1981) that the leakiness that is sometimes associated with tumor vasculature (Brown et al., 1988;Gerlowski and Jain, 1986;O'Connor and Bale, 1984;Song and Levitt, 1971) may be explained, at least in part, by the production of VPF by tumors.This hypothesis is supported by experiments in which antibodies against VPF were shown to inhibit the accumulation of ascites fluid in tumor-bearing animals (Senger et al., 1983).gVPF is a -40-kDa protein consisting of disulfide-linked subunits of -18-24 kDa.A single N-terminal amino acid sequence was obtained for intact gVPF and for the individual
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Morrissey, J. H. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90783-1 · Cited by 4,061
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
High resolution two-dimensional electrophoresis of basic as well as acidic proteins
O'Farrell, P. Z., Goodman, H. M., & O'Farrell, P. H. (1977) · Cell · doi:10.1016/0092-8674(77)90176-3 · Cited by 3,513
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.
Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265
Self-citationIshikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., & Heldin, C.-H. (1989) · Nature · doi:10.1038/338557a0 · Cited by 711
[36] High-sensitivity sequencing with a gas-phase sequenator
Hunkapiller, M. W., Hewick, R. M., Dreyer, W. J., & Hood, L. E. (1983) · Methods in Enzymology · doi:10.1016/s0076-6879(83)91038-8 · Cited by 659
Human Leukemic Models of Myelomonocytic Development: A Review of the HL-60 and U937 Cell Lines
Harris, P., & Ralph, P. (1985) · Journal of Leukocyte Biology · doi:10.1002/jlb.37.4.407 · Cited by 650
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Cited by
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Metadata
- Authors
- Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., & Feder, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1989-11
- Volume
- 264
- Issue
- 33
- Pages
- 20017-20024
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W4245693946
- Cited by
- 284
- References
- 18
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Vascular Permeability Factor. https://app.cochat.ai/papers/10.1016/s0021-9258(19)47212-8
- The paper
- Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., & Feder, J. (1989). Human Vascular Permeability Factor. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)47212-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.